PM
NRIX icon

Ponoi Management’s Nurix Therapeutics NRIX Stock Holding History

Ponoi Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.26M Hold
327,123
– – 5.82% 4
2022
Q2 		$4.14M Buy
327,123
+1
+0% +$11 6.54% 4
2022
Q1 		$4.58M Hold
327,122
– – 5.95% 4
2021
Q4 		$9.47M Sell
327,122
-234,451
-42% -$7.11M 8.73% 4
2021
Q3 		$16.8M Sell
561,573
-124,701
-18% -$3.85M 14.94% 4
2021
Q2 		$18.2M Hold
686,274
– – 10.12% 5
2021
Q1 		$21.3M Hold
686,274
– – 12.55% 5
2020
Q4 		$22.6M Buy
+686,274
New +$22.7M 12.91% 5

Other funds holding NRIX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return